Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.
about
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma.Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma.Hepatocellular carcinoma
P2860
Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@en
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@nl
type
label
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@en
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@nl
prefLabel
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@en
Clinical usefulness of double ...... nced hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Clinical usefulness of double ...... anced hepatocellular carcinoma
@en
P2093
Chae Yoon Chon
Do Young Kim
Jinsil Seong
Jun Young Park
Seung Up Kim
P2860
P304
P356
10.1111/LIV.12274
P577
2013-07-29T00:00:00Z